News Center

The 92nd National Pharmaceutical Fair concluded successfully at the National Exhibition and Convention Center (Shanghai) from May 13 to 15, 2026. As a leading professional brand specializing in mild respiratory tract diagnosis and treatment as well as nasal care in China, Nasol Cleanor showcased its full product portfolio at Booth E15, Hall 6.1. Selected for the High-Growth Channel Star Product Exhibition Zone of the fair, the brand stood out as a flagship fast-selling retail item on-site.

Backed by rich brand heritage and sustained quality-oriented innovation, Nasol Cleanor has forged solid market advantages. Furthermore, it has been included in the 16th Shanghai Key Trademark Protection Catalogue and won a host of industry awards, including the 2025 Most Popular Star Product Among Pharmacies.

Nasol Cleanor is among China’s few nasal care products approved for indications related to upper respiratory tract infections (URTIs). Consumers expect quick-acting relief for nasal congestion, runny nose and other acute discomforts triggered by colds, flu or acute rhinitis, a demand perfectly matching the 30-minute doorstep delivery service of O2O instant retail. Via instant retail channels, Nasol Cleanor products can be promptly delivered to users amid discomfort to address urgent healthcare needs.

In addition, Nasol Cleanor works well with common medications including cold remedies, anti-allergy drugs and intranasal corticosteroids, supporting effective bundle sales and mutual sales growth. O2O pharmacies can pair Nasol Cleanor with compatible medicines to create an optimized solution combining drug therapy and physical nasal care. This approach enhances treatment effects and customer satisfaction, while also increasing the average order value. Many buyers at the fair noted that the brand achieves strong sales and stable repurchase rates on O2O channels. More importantly, it drives growth for related product lines, making it an excellent choice for pharmacies to integrate online and offline operations and seize opportunities from instant consumption.

During the three-day event, Nasol Cleanor’s booth was continuously thronged with visitors. Its flagship products, including adjustable seawater nasal irrigators, seawater nasal sprays for URTI indications and the Xiaonuo Eye Protection Spray, drew numerous buyers from chain pharmacies, O2O platforms and medical practitioners for product trials and business discussions.

As the flagship core brand of listed firm Apon Medical, Nasol Cleanor has stayed committed to innovation and quality upgrading over the past 18 years. Its milestones span clinical research and health popularization, patented formulations and product form iteration, sequential treatment for segmented ailments and groundbreaking approval for URTI indications, semi-automatic production lines to Jiangsu’s first batch of certified smart manufacturing workshops, as well as expansion from nasal irrigation to the strategic layout of mild respiratory tract diagnosis and treatment. All these achievements have laid the foundation for its full-spectrum empowerment system covering all sales channels, usage scenarios and consumer groups.

Moving forward, the brand will continue to fuel market expansion with scientific research, deliver sustainable value for partners and spearhead a new growth phase across the mild respiratory tract diagnosis and treatment industry.